Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age

Abstract Background Fertility-sparing surgery is indicated for patients with stage I epithelial ovarian cancers. We sought to evaluate the clinical outcomes and oncofertility in a cohort of patients of reproductive age with stage I epithelial ovarian cancer (EOC). Methods Overall, 108 patients of re...

Full description

Bibliographic Details
Main Authors: Xuan Jiang, Jiaxin Yang, Mei Yu, Weimin Xie, Dongyan Cao, Ming Wu, Lingya Pan, Huifang Huang, Yan You, Keng Shen
Format: Article
Language:English
Published: BMC 2017-08-01
Series:World Journal of Surgical Oncology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12957-017-1222-4
_version_ 1818849967767289856
author Xuan Jiang
Jiaxin Yang
Mei Yu
Weimin Xie
Dongyan Cao
Ming Wu
Lingya Pan
Huifang Huang
Yan You
Keng Shen
author_facet Xuan Jiang
Jiaxin Yang
Mei Yu
Weimin Xie
Dongyan Cao
Ming Wu
Lingya Pan
Huifang Huang
Yan You
Keng Shen
author_sort Xuan Jiang
collection DOAJ
description Abstract Background Fertility-sparing surgery is indicated for patients with stage I epithelial ovarian cancers. We sought to evaluate the clinical outcomes and oncofertility in a cohort of patients of reproductive age with stage I epithelial ovarian cancer (EOC). Methods Overall, 108 patients of reproductive age (≤ 40 years) diagnosed with stage I EOC who were treated at Peking Union Medical College Hospital between 1999 and 2013 were included in the study. The Kaplan-Meier model and Cox regression analyses were used for the survival analysis. Results The type of surgery included fertility-sparing surgery (FSS) (48.1%) and radical surgery (RS) (51.9%). After a median follow-up of 83 months, we observed that grade 3 or clear-cell carcinoma was the only independent risk factor for disease-free survival and tumor-specific survival in the multivariate analysis. Patients with grade 3 or clear-cell carcinoma tended to be older than 30 years, have endometriosis, and undergo RS (p < 0.05). Fertility-sparing surgery did not affect disease-free survival or tumor-specific survival among patients of reproductive age with stage I EOC and among high-risk patients with stage IC2-3, grade 3, or clear-cell carcinoma. Thirty-four out of 52 (65.4%) FSS patients attempted to get pregnant. Twenty-eight (82.4%) achieved a successful pregnancy with a full-term delivery. Conclusions Grade 3 or clear-cell carcinoma was the only independent risk factor for survival of patients of reproductive age with stage I EOC. FSS can be safely performed on patients of reproductive age with grade 1-2, stage I EOC. The safety of FSS for grade 3 and clear-cell carcinoma warrants further investigation.
first_indexed 2024-12-19T06:41:39Z
format Article
id doaj.art-7d84051e3dc2465b8e0ccf34e2410cd2
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-19T06:41:39Z
publishDate 2017-08-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-7d84051e3dc2465b8e0ccf34e2410cd22022-12-21T20:32:02ZengBMCWorld Journal of Surgical Oncology1477-78192017-08-0115111110.1186/s12957-017-1222-4Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive ageXuan Jiang0Jiaxin Yang1Mei Yu2Weimin Xie3Dongyan Cao4Ming Wu5Lingya Pan6Huifang Huang7Yan You8Keng Shen9Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical CollegeDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical CollegeDepartment of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical CollegeAbstract Background Fertility-sparing surgery is indicated for patients with stage I epithelial ovarian cancers. We sought to evaluate the clinical outcomes and oncofertility in a cohort of patients of reproductive age with stage I epithelial ovarian cancer (EOC). Methods Overall, 108 patients of reproductive age (≤ 40 years) diagnosed with stage I EOC who were treated at Peking Union Medical College Hospital between 1999 and 2013 were included in the study. The Kaplan-Meier model and Cox regression analyses were used for the survival analysis. Results The type of surgery included fertility-sparing surgery (FSS) (48.1%) and radical surgery (RS) (51.9%). After a median follow-up of 83 months, we observed that grade 3 or clear-cell carcinoma was the only independent risk factor for disease-free survival and tumor-specific survival in the multivariate analysis. Patients with grade 3 or clear-cell carcinoma tended to be older than 30 years, have endometriosis, and undergo RS (p < 0.05). Fertility-sparing surgery did not affect disease-free survival or tumor-specific survival among patients of reproductive age with stage I EOC and among high-risk patients with stage IC2-3, grade 3, or clear-cell carcinoma. Thirty-four out of 52 (65.4%) FSS patients attempted to get pregnant. Twenty-eight (82.4%) achieved a successful pregnancy with a full-term delivery. Conclusions Grade 3 or clear-cell carcinoma was the only independent risk factor for survival of patients of reproductive age with stage I EOC. FSS can be safely performed on patients of reproductive age with grade 1-2, stage I EOC. The safety of FSS for grade 3 and clear-cell carcinoma warrants further investigation.http://link.springer.com/article/10.1186/s12957-017-1222-4Fertility-sparing surgeryEpithelial ovarian cancerStage IReproductive ageSurvival
spellingShingle Xuan Jiang
Jiaxin Yang
Mei Yu
Weimin Xie
Dongyan Cao
Ming Wu
Lingya Pan
Huifang Huang
Yan You
Keng Shen
Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age
World Journal of Surgical Oncology
Fertility-sparing surgery
Epithelial ovarian cancer
Stage I
Reproductive age
Survival
title Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age
title_full Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age
title_fullStr Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age
title_full_unstemmed Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age
title_short Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age
title_sort oncofertility in patients with stage i epithelial ovarian cancer fertility sparing surgery in young women of reproductive age
topic Fertility-sparing surgery
Epithelial ovarian cancer
Stage I
Reproductive age
Survival
url http://link.springer.com/article/10.1186/s12957-017-1222-4
work_keys_str_mv AT xuanjiang oncofertilityinpatientswithstageiepithelialovariancancerfertilitysparingsurgeryinyoungwomenofreproductiveage
AT jiaxinyang oncofertilityinpatientswithstageiepithelialovariancancerfertilitysparingsurgeryinyoungwomenofreproductiveage
AT meiyu oncofertilityinpatientswithstageiepithelialovariancancerfertilitysparingsurgeryinyoungwomenofreproductiveage
AT weiminxie oncofertilityinpatientswithstageiepithelialovariancancerfertilitysparingsurgeryinyoungwomenofreproductiveage
AT dongyancao oncofertilityinpatientswithstageiepithelialovariancancerfertilitysparingsurgeryinyoungwomenofreproductiveage
AT mingwu oncofertilityinpatientswithstageiepithelialovariancancerfertilitysparingsurgeryinyoungwomenofreproductiveage
AT lingyapan oncofertilityinpatientswithstageiepithelialovariancancerfertilitysparingsurgeryinyoungwomenofreproductiveage
AT huifanghuang oncofertilityinpatientswithstageiepithelialovariancancerfertilitysparingsurgeryinyoungwomenofreproductiveage
AT yanyou oncofertilityinpatientswithstageiepithelialovariancancerfertilitysparingsurgeryinyoungwomenofreproductiveage
AT kengshen oncofertilityinpatientswithstageiepithelialovariancancerfertilitysparingsurgeryinyoungwomenofreproductiveage